Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib
| Autor: | Guttman-Yassky, Emma, Mita, Alain, De Jonge, Maja, Matthews, Lesley, McCarthy, Sean, Iwata, Kenneth K., Verweij, Jaap, Rowinsky, Eric K., Krueger, James G. |
|---|---|
| Zdroj: | In European Journal of Cancer 2010 46(11):2010-2019 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect